Clinibase’s Post

Are you struggling with duplicate and professional research subjects? Look no further than Verified Clinical Trials ™ (VCT)! VCT is a cross-sponsor database that covers phase I-IV across multiple therapeutic indications globally. With VCT, you can save time and money while ensuring your clinical trial meets its endpoints. Contact VCT at connect@verifiedclinicaltrials.com to learn more! #duplicatesubjects #verifiedclinicaltrials #placebo

Are you struggling with duplicate and professional research subjects? Look no further than Verified Clinical Trials ™ (VCT)! VCT is a cross-sponsor database that covers phase I-IV across multiple therapeutic indications globally. With VCT, you can save time and money while ensuring your clinical trial meets its endpoints. Contact VCT at connect@verifiedclinicaltrials.com to learn more! #duplicatesubjects #verifiedclinicaltrials #placebo

Are you struggling with duplicate and professional research subjects? Look no further than Verified Clinical Trials ™ (VCT)! VCT is a cross-sponsor database that covers phase I-IV across multiple therapeutic indications globally. With VCT, you can save time and money while ensuring your clinical trial meets its endpoints. Contact VCT at connect@verifiedclinicaltrials.com to learn more! #duplicatesubjects #verifiedclinicaltrials #placebo

Are you struggling with duplicate and professional research subjects? Look no further than Verified Clinical Trials ™ (VCT)! VCT is a cross-sponsor database that covers phase I-IV across multiple therapeutic indications globally. With VCT, you can save time and money while ensuring your clinical trial meets its endpoints. Contact VCT at connect@verifiedclinicaltrials.com to learn more! #duplicatesubjects #verifiedclinicaltrials #placebo

Are you struggling with duplicate and professional research subjects? Look no further than Verified Clinical Trials ™ (VCT)! VCT is a cross-sponsor database covering phase I-IV across multiple therapeutic indications globally. With VCT, you can save time and money while ensuring your clinical trial meets its endpoints. Contact VCT at connect@verifiedclinicaltrials.com to learn more! #duplicatesubjects #verifiedclinicaltrials #placeboresponse

What place do home visits have in clinical trials……Find out at this EUCROF25 Speaker’s presentation…… EUCROF is thrilled to announce that Geert Briers (Deltaclinical) will be joining us at EUCROF25 to present “Clinical trial home visits, do's and dont’s.” In this engaging talk, Geert will evaluate the practical aspects of the benefits and challenges of home visits in clinical studies. Join his talk for a detailed insight into the incorporation of home visits into a protocol. View the programme for EUCROF25 here: https://lnkd.in/eEYsx8WT Dr. Martine Dehlinger-Kremer, Simon Lee, Martin O'Kane, Sverre Bengtsson, Benedikt Van Nieuwenhove, Alexandre Malouvier, Antonio Torres, Nicole Bohrmann, Cristina Florescu Moraid, Alan Yeomans, Nira Garty #EUCROF #clinicalresearch #clinicaltrials #clinicaloperations #gcp #bigpharma #dct #EUCROF25

TRIAL NEWS 📣: The Partnership for Advancing Clinical Trials (PACT) consortium, in conjunction with the Tufts Center for the Study of Drug Development, has produced compelling results from a new study on the effectiveness of decentralized clinical trials (DCTs)🔬. In total, 13 clinical trial sponsors & CROs provided robust data on 60 clinical trials that deployed decentralized solutions. The analysis found that actual timelines beat planned timelines from first site activated to first patient enrolled, & from first patient to last patient enrolled ⏩. Early results of the PACT research also suggest that trials with DCT elements have more diverse study volunteers than those without, including a lower percentage of white participants, and higher percentage of Asian participants. Read more here: https://lnkd.in/eevNTkMW ________ Michelle Longmire, Pamela Tenaerts, MD, MBA, Tim Smith, Alison Holland, Jason Rothbart #clinicaltrials #clinicalresearch #healthcare #digitalhealth

💚 Why I LOVE Being Part of AK Clinical Research 💚 Strong team? Check ✅ Solid partners? Double-check. ✅✅ Together, we’re like the Avengers of clinical trials, but instead of fighting bad guys, we're battling health challenges. Since we began in 2019, we have embarked on 25 clinical trials, each one pushing us to new heights. Talk about a hive of activity! 🐝- - - - 🌱 🖐 Need a helping hand? 🖐 🔗 Join our journey! Follow AK Clinical Research here on LinkedIn to get updates and insights into the work we do and the difference we make. Still curious about our superpowers? Check out our website to learn more! https://lnkd.in/ddFFQ3EU #ProudTeamMember #ClinicalTrials #HealthcareInnovation #Teamwork #CRO #Biotech #ResearchExcellence

Join us next week at the 2024 ISPE Annual Meeting in Berlin on August 28th from 8:00 AM – 1:30 PM for a fascinating poster session presented by AbbVie. Dive into the world of "Unlocking Insights: Lessons Learned from the Tokenization of a Psoriasis Trial" By generating unique patient IDs from personal identifying information, tokenization allows for the seamless integration of clinical trial data with real-world data (RWD), enhancing the capture of comorbidities and drug exposure before a trial even begins. In a recent pilot study using ConcertAI’s claims dataset, researchers successfully integrated trial data with RWD through tokenization, providing valuable insights into the baseline characteristics of trial participants. The results showed a high overlap between trial participants and information in open claims, with some discrepancies noted in closed claims. Despite minor discrepancies in baseline comorbidities between the RCT and RWD populations, the integration of data through tokenization has opened up new possibilities for understanding patient profiles and treatment outcomes. These initial findings highlight the potential of tokenization in bridging the gap between clinical trial data and real-world evidence. Read the abstract to learn more: https://hubs.ly/Q02M6b1D0 #Tokenization #HealthcareResearch #DataIntegration #ClinicalTrials #RWD #HIPAACompliant #PatientID #InnovativeResearch #ISPE2024

Just over a week to go to the next PCSIG webinar, hosted by The Evidence Base®. Register today! In this webinar, members of the PCSIG Board will talk about a number of activities that the group has undertaken in 2024, along with plans for the future and how you can get involved. Moderated by Neil Spooner This includes details of the establishment of the PCSIG Patient Advisory Group, the PCSIG Sponsors Advisory Group, our workshop "incorporating PCS approaches into multi-site clinical trials", our webinars, website and other activities aimed at increasing the awareness of patient centric sampling approaches and overcoming the barriers for their more widespread adoption. Made possible by the PCSIG sponsors: Altasciences, Alturas Analytics, Inc., Artyc, BENTO BIOLOGY PLATFORMS, Capitainer, Charles River Laboratories, Genentech, GSK, MSD, Neoteryx, IQVIA Laboratories, RedDrop Dx, Resolian, Roche, Slope, Takeda, Tasso, Inc., Veloxity Labs, LLC and Waters Corporation. #microsampling #patientcentricity #bloodsamples